METTL21D Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-69017
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: EIEGFPSPPDFILMADCIYYEESLEPLLKTLKDISGFETCIICCYEQRTMGKNPEIEKKYFELLQLDFDFEKIPLEKHDEEYRSEDIHIIYIRKK
Reactivity Notes
Mouse 85%
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for METTL21D Antibody
Immunocytochemistry/ Immunofluorescence: METTL21D Antibody [NBP2-69017]
Immunocytochemistry/Immunofluorescence: METTL21D Antibody [NBP2-69017] - Staining of human cell line REH shows localization to cytosol. Antibody staining is shown in green.Applications for METTL21D Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
ICC/IF Fixation/Permeabilization: PFA/Triton X-100
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: METTL21D
Alternate Names
C14orf138, FLJ13920, methyltransferase like 21D, methyltransferase-like protein 21D
Gene Symbol
VCPKMT
Additional METTL21D Products
Product Documents for METTL21D Antibody
Product Specific Notices for METTL21D Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...